Share
Other content recommended for you
- With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
- Psychedelic crossings: American mental health and LSD in the 1970s
- Research abuses against people of colour and other vulnerable groups in early psychedelic research
- Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
- Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement
- UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study
- Chronic pain and psychedelics: a review and proposed mechanism of action
- PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS
- Perioperative considerations for patients exposed to hallucinogens
- Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches